|
1
|
Carmeliet P and Baes M: Metabolism and
therapeutic angiogenesis. N Engl J Med. 358:2511–2512. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Berz D and Wanebo H: Targeting the growth
factors and angiogenesis pathways: Small molecules in solid tumors.
J Surg Oncol. 103:574–586. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Burstein HJ and Schwartz RS: Molecular
origins of cancer. N Engl J Med. 358:5272008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carmeliet P and Jain RK: Molecular
mechanisms and clinical applications of angiogenesis. Nature.
473:298–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kerbel RS: Tumor angiogenesis. N Engl J
Med. 358:2039–2049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferrara N: Vascular endothelial growth
factor: Basic science and clinical progress. Endocr Rev.
25:581–611. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pyun BJ, Choi S, Lee Y, Kim TW, Min JK,
Kim Y, Kim BD, Kim JH, Kim TY, Kim YM and Kwon YG: Capsiate, a
nonpungent capsaicin-like compound, inhibits angiogenesis and
vascular permeability via a direct inhibition of Src kinase
activity. Cancer Res. 68:227–235. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fu XY, Zhang S, Wang K, Yang MF, Fan CD
and Sun BL: Caudatin inhibits human glioma cells growth through
triggering DNA damage-mediated cell cycle arrest. Cell Mol
Neurobiol. 35:953–959. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li X, Zhang M, Xiang C, Qin Y, He J, Li BC
and Li P: C21 steroids from roots of Cynanchum otophyllum. Zhongguo
Zhong Yao Za Zhi. 39:1450–1456. 2014.(In Chinese). PubMed/NCBI
|
|
10
|
Peng Y and Ding Y: Pharmacokinetics and
tissue distribution study of caudatin in normal and
diethylnitrosamine-induced hepatocellular carcinoma model rats.
Molecules. 20:4225–4237. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang YQ, Yang B, Zhang RS and Wei EQ:
Inhibitive effect of C-21 steroidal glycosides of Cynanchum
auriculatum on rat glioma cells in vitro. Zhejiang Da Xue Xue Bao
Yi Xue Ban. 40:402–407. 2011.(In Chinese). PubMed/NCBI
|
|
12
|
Wang YQ, Zhang SJ, Lu H, Yang B, Ye LF and
Zhang RS: A C 21 -steroidal glycoside isolated from the roots of
cynanchum auriculatum induces cell cycle arrest and apoptosis in
human gastric cancer SGC-7901 cells. Evid Based Complement Alternat
Med. 2013:1808392013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu LZ, Hou YJ, Zhao M, Yang MF, Fu XT,
Sun JY, Fu XY, Shao LR, Zhang HF, Fan CD, et al: Caudatin induces
caspase-dependent apoptosis in human glioma cells with involvement
of mitochondrial dysfunction and reactive oxygen species
generation. Cell Biol Toxicol. 32:333–345. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Luo Y, Sun Z, Li Y, Liu L, Cai X and Li Z:
Caudatin inhibits human hepatoma cell growth and metastasis through
modulation of the Wnt/β-catenin pathway. Oncol Rep. 30:2923–2928.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peng YR, Ding YF, Wei YJ, Shu B, Li YB and
Liu XD: Caudatin-2,6-dideoxy-3-O-methy-β-D-cymaropyranoside 1
induced apoptosis through caspase 3-dependent pathway in human
hepatoma cell line SMMC7721. Phytother Res. 25:631–637. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fei HR, Chen HL, Xiao T, Chen G and Wang
FZ: Caudatin induces cell cycle arrest and caspase-dependent
apoptosis in HepG2 cell. Mol Biol Rep. 39:131–138. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang LJ, Chen H, Ma YB, Huang XY, Geng CA,
Zhang XM and Chen JJ: Design, synthesis and biological evaluation
of caudatin analogs as potent hepatitis B virus inhibitors. Med
Chem. 11:165–179. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fei HR, Cui LY, Zhang ZR, Zhao Y and Wang
FZ: Caudatin inhibits carcinomic human alveolar basal epithelial
cell growth and angiogenesis through modulating GSK3β/β-catenin
pathway. J Cell Biochem. 113:3403–3410. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li X, Zhang X, Liu X, Tan Z, Yang C, Ding
X, Hu X, Zhou J, Xiang S, Zhou C and Zhang J: Caudatin induces cell
apoptosis in gastric cancer cells through modulation of
Wnt/β-catenin signaling. Oncol Rep. 30:677–684. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Aggarwal BB and Shishodia S: Molecular
targets of dietary agents for prevention and therapy of cancer.
Biochem Pharmacol. 71:1397–1421. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ren W, Qiao Z, Wang H, Zhu L and Zhang L:
Flavonoids: Promising anticancer agents. Med Res Rev. 23:519–534.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Carmeliet P, Dor Y, Herbert JM, Fukumura
D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R,
Maxwell P, et al: Role of HIF-1alpha in hypoxia-mediated apoptosis,
cell proliferation and tumour angiogenesis. Nature. 394:485–490.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bolat F, Haberal N, Tunali N, Aslan E, Bal
N and Tuncer I: Expression of vascular endothelial growth factor
(VEGF), hypoxia inducible factor 1 alpha (HIF-1alpha), and
transforming growth factors beta1 (TGFbeta1) and beta3 (TGFbeta3)
in gestational trophoblastic disease. Pathol Res Pract. 206:19–23.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carmeliet P: Angiogenesis in life, disease
and medicine. Nature. 438:932–936. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ferrara N and Kerbel RS: Angiogenesis as a
therapeutic target. Nature. 438:967–974. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Holopainen T, Bry M, Alitalo K and
Saaristo A: Perspectives on lymphangiogenesis and angiogenesis in
cancer. J Surg Oncol. 103:484–488. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nussenbaum F and Herman IM: Tumor
angiogenesis: Insights and innovations. J Oncol. 2010:1326412010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ferrara N: VEGF and the quest for tumour
angiogenesis factors. Nat Rev Cancer. 2:795–803. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Le Boeuf F, Houle F and Huot J: Regulation
of vascular endothelial growth factor receptor 2-mediated
phosphorylation of focal adhesion kinase by heat shock protein 90
and Src kinase activities. J Biol Chem. 279:39175–39185. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jośko J and Mazurek M: Transcription
factors having impact on vascular endothelial growth factor (VEGF)
gene expression in angiogenesis. Med Sci Monit. 10:RA89–RA98.
2004.PubMed/NCBI
|
|
31
|
Parsons JT: Focal adhesion kinase: The
first ten years. J Cell Sci. 116:1409–1416. 2013. View Article : Google Scholar
|
|
32
|
Braren R, Hu H, Kim YH, Beggs HE,
Reichardt LF and Wang R: Endothelial FAK is essential for vascular
network stability, cell survival, and lamellipodial formation. J
Cell Biol. 172:151–162. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Holmqvist K, Cross MJ, Rolny C, Hägerkvist
R, Rahimi N, Matsumoto T, Claesson-Welsh L and Welsh M: The adaptor
protein shb binds to tyrosine 1175 in vascular endothelial growth
factor (VEGF) receptor-2 and regulates VEGF-dependent cellular
migration. J Biol Chem. 279:22267–22275. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qi JH and Claesson-Welsh L: VEGF-induced
activation of phosphoinositide 3-kinase is dependent on focal
adhesion kinase. Exp Cell Res. 263:173–182. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mitra SK, Mikolon D, Molina JE, Hsia DA,
Hanson DA, Chi A, Lim ST, Bernard-Trifilo JA, Ilic D, Stupack DG,
et al: Intrinsic FAK activity and Y925 phosphorylation facilitate
an angiogenic switch in tumors. Oncogene. 25:5969–5984. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shen TL, Park AY, Alcaraz A, Peng X, Jang
I, Koni P, Flavell RA, Gu H and Guan JL: Conditional knockout of
focal adhesion kinase in endothelial cells reveals its role in
angiogenesis and vascular development in late embryogenesis. J Cell
Biol. 169:941–952. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shiojima I and Walsh K: Role of Akt
signaling in vascular homeostasis and angiogenesis. Circ Res.
90:1243–1250. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vara JA Fresno, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang BH, Zheng JZ, Aoki M and Vogt PK:
Phosphatidylinositol 3-kinase signaling mediates angiogenesis and
expression of vascular endothelial growth factor in endothelial
cells. Proc Natl Acad Sci USA. 97:pp. 1749–1753. 2000; View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fan C, Zheng W, Fu X, Li X, Wong YS and
Chen T: Enhancement of auranofin-induced lung cancer cell apoptosis
by selenocystine, a natural inhibitor of TrxR1 in vitro and in
vivo. Cell Death Dis. 5:e11912014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fan C, Zheng W, Fu X, Li X, Wong YS and
Chen T: Strategy to enhance the therapeutic effect of doxorubicin
in human hepatocellular carcinoma by selenocystine, a synergistic
agent that regulates the ROS-mediated signaling. Oncotarget.
5:2853–2563. 2014. View Article : Google Scholar : PubMed/NCBI
|
